Test Price
1,800 AED✅ Home Collection Available
C5 Complement Test in UAE | 1800 AED | DHA Licensed Lab in Dubai Healthcare City
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM)
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Core Metric Snapshot
- Price: 1800 AED (Inclusive of VAT)
- Turnaround: 2–3 weeks (batch analysis with rigorous quality control)
- Methodology: Radial Immunodiffusion (RID) – gold standard for complement component quantification
- DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City
Test Overview & Methodology
The C5 Complement Test quantitatively measures the fifth component of the complement system, an essential pillar of innate immune defense. This serum protein assessment aids in diagnosing primary complement deficiencies and monitoring complement-consuming disorders such as systemic lupus erythematosus or recurrent Neisserial infections. The test employs Radial Immunodiffusion (RID), a classic, robust method standardized over decades, ensuring accurate protein quantification in accordance with international clinical laboratory standards.
| Feature | Our C5 Complement Test (RID) | Closest Alternative (Nephelometry) |
|---|---|---|
| Methodology Precision | Radial Immunodiffusion – direct antigen-antibody precipitation; gold standard for rare complement component quantification | Automated Nephelometry – kinetic light scatter; may cross-react with other serum proteins |
| Turnaround Time | 2–3 weeks (batch analysis ensures rigorous quality control) | 24–48 hours (rapid screening but less specific for C5) |
| Regulatory Alignment | Fully compliant with Federal Decree-Law No. 45 of 2021 (PDPL), Federal Law No. 2 of 2019 on health ICT, and Federal Decree-Law No. 4 of 2016 on Medical Liability | May not explicitly address UAE-specific consent and data privacy mandates |
Physician Insight & Safety Protocols
"Quantitative C5 measurement offers a critical window into terminal complement pathway integrity, especially in patients presenting with unexplained recurrent Neisserial infections or atypical hemolytic uremic syndrome. Clinical interpretation must integrate functional complement assays, CH50 levels, and the full immunophenotype. Our team provides telephonic case discussion support for all referring physicians."
– Dr. Ajay Singh, General Practitioner (DHA Registration ID: 36234132)
⚠️ Critical Medication Safety Advisory
Patients receiving complement inhibitor therapy (e.g., eculizumab) must never alter or discontinue their prescribed dosing regimen without direct supervision by their treating specialist. Interruption of therapy may precipitate severe complications including hemolytic crisis, thrombotic events, or life-threatening infection. Contact your physician immediately if a dose is missed.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Active systemic infection within 14 days prior to sampling (may falsely elevate complement levels); incomplete patient consent documentation per PDPL and Medical Liability Law requirements.
- Emergency red flags – do NOT wait for results: Signs of meningococcal sepsis (petechial rash, severe headache, neck stiffness), sudden vision loss, or severe abdominal pain. Proceed immediately to the nearest Emergency Department.
- Sample rejection criteria: Hemolyzed, lipemic, or thawed specimens will be rejected. A properly executed consent form must accompany all samples.
Patient FAQ & Clinical Guidance
1. What does a low C5 complement result indicate in the context of recurrent Neisseria infections?
A low C5 level strongly suggests a congenital terminal complement deficiency, which impairs the membrane attack complex and specifically predisposes patients to invasive meningococcal and gonococcal diseases because the lytic pathway is ineffective against these encapsulated bacteria.
2. How should I prepare for the C5 Complement Test and why is the consent process mandatory?
Fasting is not required. You must complete the standard patient consent form to authorize sample processing and shipment to our reference laboratory. This requirement ensures full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Decree-Law No. 4 of 2016 on Medical Liability. Without signed consent, the sample cannot be accepted.
3. Can children undergo this test, and what special protections apply under UAE law?
Yes, pediatric testing is available. UAE law requires additional parental or guardian consent along with a documented clinical justification from the requesting physician. Our phlebotomy team uses pediatric-specific protocols to minimize discomfort and ensure accurate venous sampling. Home collection is available daily from 8 AM to 11 PM with our temperature-controlled cold chain logistics.
4. How does the 2–3 week turnaround time affect clinical decision-making?
The extended turnaround reflects batch analysis methodology, which ensures rigorous quality control and precise quantification via Radial Immunodiffusion. For urgent clinical assessments, your physician may order concurrent functional complement assays (CH50) while awaiting quantitative C5 results. Our team can facilitate expedited case discussion upon request.
5. What is the difference between this C5 test and a standard complement panel?
A standard complement panel typically measures C3 and C4 proteins. The C5 Complement Test specifically quantifies the fifth component, which is critical for assessing the terminal complement pathway. Isolated C5 deficiency is strongly associated with recurrent Neisserial infections and cannot be inferred from C3 or C4 levels alone.
UAE Regulatory & Data Privacy Adherence
- DHA Facility License: 1143 issued by Dubai Health Authority for clinical laboratory operations in Dubai Healthcare City.
- Data Protection: All patient data processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL). No third-party data sharing without explicit written patient authorization.
- Health ICT Compliance: Information systems and electronic health records maintained per Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Medical Liability: Clinical testing safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Quality Accreditation: ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139) ensuring standardized pre-analytical, analytical, and post-analytical processes.
- Patient Support: Direct billing verification, home collection scheduling, and clinical query escalation available via WhatsApp at +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | C5 Complement Test (Complement Component C5, Serum) |
| Price (AED) | 1,800 AED (Inclusive of VAT) |
| Turnaround Time | 2–3 weeks (batch analysis with quality control) |
| Sample Type / Matrix | Serum (peripheral venipuncture) |
| Methodology Used | Radial Immunodiffusion (RID) – quantitative antigen-antibody precipitation |
| ICD-10-CM Code | D84.1 (Defects in the complement system) |
| LOINC Code | 41486-6 (Complement C5 [Mass/volume] in Serum) |
| DHA Facility License & Laboratory Address | License No. 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians